Patient Benefit Management (PBM)
Taiwan has national health insurance and does not need a US-style PBM. The real gap sits outside it — self-pay innovative medicines and uncovered care. We design, manage and run that layer of drug and care benefits for employers and insurers, with MediPASS carrying members, payment rules, the partner network and settlement.
Four building blocks
Design a formulary for each employer or insurer: self-pay medicine subsidies, vaccines and screening, chronic care and long-term care support. Payment rules are written straight into MediPASS — no second system required.
Value for three audiences
PAP disbursement lacks compliant infrastructure, and the self-pay market lacks a channel to reach eligible patients.
Upgrade PAP into an auditable benefit payment system and widen the eligible-patient funnel through employer and insurer channels.
Why Taiwan needs its own PBM
This industry report covers market sizing outside national insurance, a comparison of localization models, and adoption paths and cost structures for employers and insurers. Leave your work email and we will send it to you when the report is released.
By submitting you agree we may contact you at this address. We never resell your data.